These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23558496)

  • 1. Patient management problem.
    Pierce A
    Continuum (Minneap Minn); 2013 Apr; 19(2 Dementia):519-37. PubMed ID: 23558496
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates in the Management of Mild Cognitive Impairment and Alzheimer Disease.
    Small GW
    J Fam Pract; 2022 Jul; 71(6 Suppl):S82-S87. PubMed ID: 35960951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gait as the Key Symptom: Neurophysiological Analysis supplements Clinical Diagnosis at First Glance].
    Dieterich M
    Fortschr Neurol Psychiatr; 2017 Jan; 85(1):15-16. PubMed ID: 28114690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of cognitive disorders in general practice].
    Hewer W; Britsch E; Haupt M
    MMW Fortschr Med; 2015 May; 157(9):54-8; quiz 59-60. PubMed ID: 26012829
    [No Abstract]   [Full Text] [Related]  

  • 5. Mythos Alzheimer?
    Longerich B
    Krankenpfl Soins Infirm; 2017; 110(3):12-13. PubMed ID: 30513144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cognitive stimulation in Alzheimer's disease].
    Fayel A; Indart S; Ortiz MS
    Rev Prat; 2020 Feb; 70(2):174-176. PubMed ID: 32877132
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Jia J; Gauthier S; Pallotta S; Ji Y; Wei W; Xiao S; Peng D; Guo Q; Wu L; Chen S; Kuang W; Zhang J; Wei C; Tang Y
    Alzheimers Dement; 2017 May; 13(5):592-597. PubMed ID: 28238739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing Alzheimer's: a pragmatic approach.
    Menchola M; Weiss BD
    J Fam Pract; 2015 Jan; 64(1):10-8. PubMed ID: 25574508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy].
    Shoji M
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):630-6. PubMed ID: 24796129
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore.
    Ng A; Chew I; Narasimhalu K; Kandiah N
    Singapore Med J; 2013 Nov; 54(11):616-9. PubMed ID: 24276096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rethinking Alzheimer's diseases].
    Hugon J
    Rev Prat; 2011 Sep; 61(7):918-9. PubMed ID: 22039724
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer disease: Penalized regression can predict conversion to AD.
    Chase A
    Nat Rev Neurol; 2015 Jul; 11(7):368. PubMed ID: 26055469
    [No Abstract]   [Full Text] [Related]  

  • 13. Memory loss.
    Flicker LA; Ford AH; Beer CD; Almeida OP
    Med J Aust; 2012 Feb; 196():114-7. PubMed ID: 22304604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.
    Gopalakrishna G; Brunton S; Pruzin J; Alford S; Hamersky C; Sabharwal A
    BMC Psychiatry; 2023 Oct; 23(1):716. PubMed ID: 37794326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment.
    Muayqil T
    Neurosciences (Riyadh); 2016 Jan; 21(1):81-3. PubMed ID: 27224973
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    Kirsebom BE; Espenes R; Waterloo K; Hessen E; Johnsen SH; Bråthen G; Aarsland D; Fladby T
    J Alzheimers Dis; 2017; 60(4):1621-1631. PubMed ID: 28984581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmacological interventions and neuroplasticity in early stage Alzheimer's disease.
    Herholz SC; Herholz RS; Herholz K
    Expert Rev Neurother; 2013 Nov; 13(11):1235-45. PubMed ID: 24134650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis.
    Duan Y; Lu L; Chen J; Wu C; Liang J; Zheng Y; Wu J; Rong P; Tang C
    BMC Geriatr; 2018 Aug; 18(1):175. PubMed ID: 30086714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of longitudinal cohort studies in understanding risk and protective factors for dementia.
    O'Brien JT
    Int Psychogeriatr; 2014 Apr; 26(4):541-2. PubMed ID: 24576781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.